Please use this identifier to cite or link to this item: https://hdl.handle.net/11147/11799
Full metadata record
DC FieldValueLanguage
dc.contributor.authorIşık, Arda-
dc.contributor.authorSoran, Atilla-
dc.contributor.authorGrasi, Ariel-
dc.contributor.authorBarry, Noran-
dc.contributor.authorSezgin, Efe-
dc.date.accessioned2021-12-02T18:16:12Z-
dc.date.available2021-12-02T18:16:12Z-
dc.date.issued2021-
dc.identifier.issn1539-6851-
dc.identifier.issn1557-8585-
dc.identifier.urihttps://doi.org/10.1089/lrb.2020.0093-
dc.identifier.urihttps://hdl.handle.net/11147/11799-
dc.description.abstractAim: Sentinel lymph node biopsy (SLNB) is the accepted approach to stage the clinically negative axilla. The incidence of lymphedema (LE) after SLNB is about 5%. We hypothesize that patients undergoing axillary excision of >5 lymph nodes (LNs) are at increased risk of developing LE. Methods and Results: A single institution prospective breast cancer database was retrospectively reviewed from January 2013 to December 2017, to identify patients who underwent SLNB and were diagnosed with LE. Inclusion criteria was (1) de novo breast cancer, (2) SLNB in clinically node negative patients, and (3) no preoperative diagnosis LE of an extremity. Exclusion criteria was history of axillary lymph node dissection. Age, body mass index, tumor-node-metastasis status, surgery type, neoadjuvant or adjuvant chemotherapy, radiotherapy, and hormone therapy were analyzed. Of the 3325 patients identified, 2940 patients met the inclusion criteria and were included in the final analysis. Median follow-up time was 24 months. Forty-seven (2%) patients were diagnosed with LE, and nine patients (19%) had >5 LNs excised. LE was diagnosed in 3.7% of patients who had >5 LNs excised versus 1.4% of patients with <= 5 LNs excised. Incidence of LE was higher in patients with >5 LNs excision (p = 0.006). Conclusion: Our study showed that patients have a higher likelihood of developing LE when >5 LNs are excised.en_US
dc.language.isoenen_US
dc.publisherMary Ann Liebert, Inc.en_US
dc.relation.ispartofLymphatic Research and Biologyen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBreast canceren_US
dc.subjectLymphedemaen_US
dc.titleLymphedema after sentinel lymph node biopsy: Who is at risk?en_US
dc.typeArticleen_US
dc.institutionauthorSezgin, Efe-
dc.departmentİzmir Institute of Technology. Food Engineeringen_US
dc.identifier.wosWOS:000668303900001en_US
dc.identifier.scopus2-s2.0-85129673370en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.1089/lrb.2020.0093-
dc.identifier.pmid34191608en_US
dc.identifier.wosqualityQ3-
dc.identifier.scopusqualityQ2-
item.openairetypeArticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.grantfulltextnone-
crisitem.author.dept03.08. Department of Food Engineering-
Appears in Collections:Food Engineering / Gıda Mühendisliği
PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

12
checked on Mar 22, 2024

WEB OF SCIENCETM
Citations

18
checked on Mar 16, 2024

Page view(s)

2,146
checked on Mar 25, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.